Redburn Initiates Arcellx at Buy With $109 Price Target
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $85
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $85
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $85
Arcellx Inc's Anito-cel Shows Promising Efficacy in Treating Challenging Multiple Myeloma, Merits Buy Rating
Arcellx Analyst Ratings
Cantor Fitzgerald Initiates Arcellx(ACLX.US) With Buy Rating
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $85
Buy Rating for Arcellx Inc: Operational Efficiencies and Market Advantages Over Legend/JnJ Propel Positive Outlook
Buy Rating Affirmed for Arcellx Inc. on Strong CAR-T Therapy Prospects and Financial Stability
Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)
Piper Sandler Issues a Buy Rating on Arcellx Inc (ACLX)
Arcellx Analyst Ratings
Needham Reiterates Buy on Arcellx, Maintains $81 Price Target
Arcellx Inc: A Buy Rating With Bright Prospects Ahead of IMMagine-1 Study Results and Strong Financials
Arcellx Inc: Buy Rating on Promising Clinical Trial Outcomes and Market Expansion Potential
Arcellx Inc: Buy Rating Affirmed Amid Promising Clinical Trials and Market Potential
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $85
Buy Rating Justified: Arcellx Inc's Promising CART DdBCMA Treatment and Competitive Edge Analyzed by John Newman
Arcellx Analyst Ratings